Damien Albin Douarre
๐๐จ๐ซ๐ญ๐Ÿ๐จ๐ฅ๐ข๐จ ๐”๐ฉ๐๐š๐ญ๐ž ๐Ÿ“ˆ Thank God itโ€™s Friday, hereโ€™s the weekly recap of the portfolioโ€™s adjustments. This week we welcome $VITL (Vital Farms Inc) as weโ€™re growing away from hype and over-heated tech. I also slightly reinforced $RMS.PA (Hermes International) as it dropped a little : ๐ŸŸข ๐—ก๐—ฒ๐˜„ ๐—ฏ๐˜‚๐˜† : $VITL 2.01% of the portfolioโ€™s equity @ $12.99 ๐ŸŸข ๐—ก๐—ฒ๐˜„ ๐—ฏ๐˜‚๐˜† : $RMS.PA 0.25% of the portfolioโ€™s equity @ โ‚ฌ1695.50 Anticipating a significant decline in purchasing power especially in the middle and lower classes, I looked out for companies that are positioned to benefit from such an environment. Several candidates emerged, but $VITL clearly stood out. If youโ€™re looking for a straightforward way to gain exposure to a purchasing power crisis, this is it: ๐˜๐—ต๐—ฒ ๐—ฐ๐—ผ๐—บ๐—ฝ๐—ฎ๐—ป๐˜† ๐˜€๐—ฒ๐—น๐—น๐˜€ ๐—ฒ๐—ด๐—ด๐˜€. Eggs are a staple of human nutrition. They are highly versatile, rich in protein and essential nutrients, and represent the cheapest animal-based protein on a per pound basis. When meat prices rise as they have recently, consumers naturally shift toward more affordable alternatives: first pork and chicken, and eventually eggs. As a result, eggs enjoy both stable, recurring demand and incremental demand driven by consumer substitution toward cheaper protein sources. The main challenge today lies in expanding production quickly enough to meet demand, while also managing the recurring impact of avian flu cycles. The first challenge is largely an opportunity, and $VITL is already well positioned. The company focuses on ethical, pasture raised hens and complies with increasingly strict animal welfare regulations, unlike intensive production models that are facing growing regulatory and societal pushback. The second challenge is evolving. Experts suggest that while the avian flu is becoming more persistent, its cyclical spikes are less severe than in the past. This dynamic affects egg prices and, by extension, $VITLโ€™s earnings. This brings me to why I believe the stock is currently undervalued. For eight consecutive quarters, the company materially exceeded earnings expectations. In Q1, however, easing egg shortages led to a minor earnings miss, prompting what appears to be an egg-xaggerated negative market reaction. (I HAD TO place at least one pun). Fundamentals remain very strong. The company has a debt to equity ratio of just 0.1, an operating margin of 11.6% (8.7% net margin), and egg-xcellent profitability metrics, including a 19% ROE and a 16% ROIC. Despite all this, $VITL trades at just 0.74x annual sales and 8.7x net earnings. Yes, you read that correctly. A re rating toward a more reasonable P/E multiple of 15โ€“20x would imply roughly 100% upside from current levels. Combine that with long term purchasing power pressures, and you have a credible case for a potential multibagger. On a cash side, this weekโ€™s investments brought holdings to 12.26% of the portfolio. Cheers ๐Ÿฅ‚ D.A.D $SPX500 $NSDQ100 $FRA40 ๐˜‹๐˜ช๐˜ด๐˜ค๐˜ญ๐˜ข๐˜ช๐˜ฎ๐˜ฆ๐˜ณ: ๐˜›๐˜ฉ๐˜ช๐˜ด ๐˜ฑ๐˜ฐ๐˜ด๐˜ต ๐˜ณ๐˜ฆ๐˜ง๐˜ญ๐˜ฆ๐˜ค๐˜ต๐˜ด ๐˜ฎ๐˜บ ๐˜ฑ๐˜ฆ๐˜ณ๐˜ด๐˜ฐ๐˜ฏ๐˜ข๐˜ญ ๐˜ฐ๐˜ฑ๐˜ช๐˜ฏ๐˜ช๐˜ฐ๐˜ฏ๐˜ด ๐˜ข๐˜ฏ๐˜ฅ ๐˜ช๐˜ฏ๐˜ท๐˜ฆ๐˜ด๐˜ต๐˜ฎ๐˜ฆ๐˜ฏ๐˜ต ๐˜ฅ๐˜ฆ๐˜ค๐˜ช๐˜ด๐˜ช๐˜ฐ๐˜ฏ๐˜ด. ๐˜๐˜ต ๐˜ช๐˜ด ๐˜ฏ๐˜ฐ๐˜ต ๐˜ง๐˜ช๐˜ฏ๐˜ข๐˜ฏ๐˜ค๐˜ช๐˜ข๐˜ญ ๐˜ข๐˜ฅ๐˜ท๐˜ช๐˜ค๐˜ฆ. ๐˜๐˜ฏ๐˜ท๐˜ฆ๐˜ด๐˜ต๐˜ช๐˜ฏ๐˜จ ๐˜ช๐˜ฏ๐˜ท๐˜ฐ๐˜ญ๐˜ท๐˜ฆ๐˜ด ๐˜ณ๐˜ช๐˜ด๐˜ฌ, ๐˜ข๐˜ฏ๐˜ฅ ๐˜ฑ๐˜ข๐˜ด๐˜ต ๐˜ฑ๐˜ฆ๐˜ณ๐˜ง๐˜ฐ๐˜ณ๐˜ฎ๐˜ข๐˜ฏ๐˜ค๐˜ฆ ๐˜ช๐˜ด ๐˜ฏ๐˜ฐ๐˜ต ๐˜ช๐˜ฏ๐˜ฅ๐˜ช๐˜ค๐˜ข๐˜ต๐˜ช๐˜ท๐˜ฆ ๐˜ฐ๐˜ง ๐˜ง๐˜ถ๐˜ต๐˜ถ๐˜ณ๐˜ฆ ๐˜ณ๐˜ฆ๐˜ด๐˜ถ๐˜ญ๐˜ต๐˜ด
Not investment advice. The author may have financial interests in the mentioned instruments.